Aspiriant LLC’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $258K | Sell |
3,189
-1,353
| -30% | -$130K | 0.01% | 350 |
|
|
2026
Q2 | $434K | Buy |
+4,542
| New | +$436K | 0.01% | 266 |
|
|
2025
Q1 | – | Sell |
-1,240
| Closed | -$201K | – | 291 |
|
|
2024
Q4 | $201K | Buy |
1,240
+1
| +0.1% | +$164 | 0.01% | 282 |
|
|
2024
Q3 | $202K | Buy |
+1,239
| New | +$184K | 0.01% | 285 |
|
|
2024
Q2 | – | Sell |
-1,604
| Closed | -$246K | – | 292 |
|
|
2024
Q1 | $246K | Sell |
1,604
-222
| -12% | -$33.1K | 0.01% | 283 |
|
|
2023
Q4 | $261K | Buy |
+1,826
| New | +$243K | 0.01% | 260 |
|
|
2023
Q3 | – | Sell |
-1,305
| Closed | -$208K | – | 285 |
|
|
2023
Q2 | $208K | Hold |
1,305
| – | – | 0.01% | 270 |
|
|
2023
Q1 | $206K | Buy |
+1,305
| New | +$196K | 0.01% | 267 |
|
|
2022
Q1 | – | Sell |
-1,258
| Closed | -$218K | – | 281 |
|
|
2021
Q4 | $218K | Buy |
1,258
+29
| +2% | +$4.83K | 0.01% | 260 |
|
|
2021
Q3 | $203K | Buy |
1,229
+2
| +0.2% | +$344 | 0.01% | 227 |
|
|
2021
Q2 | $221K | Hold |
1,227
| – | – | 0.01% | 221 |
|
|
2021
Q1 | $238K | Sell |
1,227
-2
| -0.2% | -$385 | 0.02% | 188 |
|
|
2020
Q4 | $248K | Hold |
1,229
| – | – | 0.02% | 186 |
|
|
2020
Q3 | $259K | Sell |
1,229
-4
| -0.3% | -$891 | 0.02% | 188 |
|
|
2020
Q2 | $271K | Sell |
1,233
-68
| -5% | -$13.6K | 0.03% | 161 |
|
|
2020
Q1 | $224K | Sell |
1,301
-45
| -3% | -$7.44K | 0.02% | 171 |
|
|
2019
Q4 | $206K | Sell |
1,346
-148
| -10% | -$22.1K | 0.02% | 193 |
|
|
2019
Q3 | $227K | Sell |
1,494
-106
| -7% | -$16.8K | 0.02% | 202 |
|
|
2019
Q2 | $244K | Sell |
1,600
-73
| -4% | -$11.2K | 0.02% | 199 |
|
|
2019
Q1 | $268K | Sell |
1,673
-734
| -30% | -$114K | 0.02% | 193 |
|
|
2018
Q4 | $370K | Sell |
2,407
-190
| -7% | -$29.6K | 0.03% | 166 |
|
|
2018
Q3 | $391K | Buy |
2,597
+34
| +1% | +$4.83K | 0.03% | 173 |
|
|
2018
Q2 | $347K | Sell |
2,563
-413
| -14% | -$51K | 0.03% | 192 |
|
|
2018
Q1 | $396K | Buy |
+2,976
| New | +$400K | 0.03% | 163 |
|
|
2017
Q4 | – | Sell |
-2,573
| Closed | -$339K | – | 99 |
|
|
2017
Q3 | $339K | Sell |
2,573
-102
| -4% | -$13.7K | 0.03% | 155 |
|
|
2017
Q2 | $356K | Sell |
2,675
-28
| -1% | -$3.78K | 0.03% | 163 |
|
|
2017
Q1 | $365K | Sell |
2,703
-254
| -9% | -$32.9K | 0.03% | 164 |
|
|
2016
Q4 | $355K | Buy |
2,957
+1
| +0% | +$118 | 0.03% | 153 |
|
|
2016
Q3 | $370K | Sell |
2,956
-351
| -11% | -$46K | 0.04% | 154 |
|
|
2016
Q2 | $389K | Buy |
3,307
+219
| +7% | +$28.4K | 0.04% | 149 |
|
|
2016
Q1 | $389K | Buy |
+3,088
| New | +$393K | 0.04% | 144 |
|
|
2015
Q4 | – | Sell |
-2,183
| Closed | -$252K | – | 85 |
|
|
2015
Q3 | $252K | Buy |
+2,183
| New | +$245K | 0.02% | 92 |
|
Other funds holding CLX
Aspiriant LLC's CLX Position: Q3 2026 in Review
Aspiriant LLC reduced its Clorox (CLX) stake by 30% in Q3 2026, selling an estimated $130K and leaving 3,189 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #350.
Aspiriant LLC first reported a position in CLX in Q3 2015 and has held it in 32 quarters since. The position peaked at $434K in Q2 2026. 233 funds tracked by Wall St. Rank hold CLX as of Q3 2026.
- Aspiriant LLC held 3,189 shares of Clorox worth $258K as of Q3 2026.
- Aspiriant LLC sold 1,353 Clorox shares in Q3 2026, an estimated $130K.
- Clorox made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #350 holding.
- Aspiriant LLC first reported a position in Clorox in Q3 2015 and has held it in 32 quarters since.
- Aspiriant LLC's Clorox position peaked at $434K in Q2 2026.
- 233 funds tracked by Wall St. Rank held Clorox as of Q3 2026.
Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.